Capstone Therapeutics Corp. (CAPS)
USD 3.0
(-11.76%)
USD 3.0
(-11.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.44 Million | -2.89 Million | 3.72 Million | 642 Thousand | -1.67 Million | 66 Thousand |
| Net Income | -3.81 Million | 2.31 Million | 3.92 Million | 8.28 Million | -999 Thousand | -753 Thousand |
| Depreciation & Amortization | 306 Thousand | 241 Thousand | 386 Thousand | 245 Thousand | 39 Thousand | 157 Thousand |
| Deferred income taxes | 32 Thousand | 525 Thousand | 524 Thousand | -8.67 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.13 Million | -5.97 Million | -327 Thousand | -2.08 Million | 734 Thousand | 36 Thousand |
| Other non-cash items | -1000.00 | 1.58 Million | -1.55 Million | -422 Thousand | -2.23 Million | 892 Thousand |
| Investing Cash Flow | -208 Thousand | -173 Thousand | -931 Thousand | -3000.00 | - | - |
| Investments in PPE | -208 Thousand | -173 Thousand | -1.17 Million | -3000.00 | - | - |
| Acquisitions | - | - | 242 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 242 Thousand | - | - | - |
| Financing Cash Flow | -1.21 Million | 3.03 Million | -2.74 Million | -697 Thousand | 396 Thousand | - |
| Debt repayment | -2.12 Million | -35 Thousand | -1.2 Million | -697 Thousand | -396 Thousand | - |
| Dividends payments | -389 Thousand | - | -3.95 Million | - | - | - |
| Common Stock Repurchased | -389 Thousand | - | -3.95 Million | - | - | - |
| Common Stock Issuance | - | - | 2.41 Million | - | - | - |
| Other Financing Activities | 1.3 Million | 3.07 Million | 3.95 Million | 780 Thousand | 46 Thousand | - |
| Accounts receivables | 4.43 Million | -4.87 Million | -1.06 Million | - | - | - |
| Accounts payables | -305 Thousand | -1.09 Million | 742 Thousand | -2.1 Million | 863 Thousand | 48 Thousand |
| Inventory | - | 4.87 Million | 1.06 Million | - | - | - |
| Other working capital | -305 Thousand | -4.87 Million | -1.06 Million | 13 Thousand | -129 Thousand | -12 Thousand |
| Cash at beginning of period | 23 Thousand | 50 Thousand | - | 58 Thousand | 1.34 Million | 1.27 Million |
| Cash at end of period | 51 Thousand | 23 Thousand | 50 Thousand | -58 Thousand | 58 Thousand | 1.34 Million |
| Capital Expenditure | -208 Thousand | -173 Thousand | -1.17 Million | -3000.00 | - | - |
| Effect of forex changes on cash | - | - | - | -58 Thousand | - | - |
| Net cash flow / Change in cash | 28 Thousand | -27 Thousand | 50 Thousand | -116 Thousand | -1.28 Million | 66 Thousand |
| Free Cash Flow | 1.24 Million | -3.06 Million | 2.55 Million | 639 Thousand | -1.67 Million | 66 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -381 Thousand | -1.11 Million | -2.01 Million | -3.81 Million | -609 Thousand | -77 Thousand |
| Depreciation & Amortization | 99 Thousand | 78 Thousand | 77 Thousand | 306 Thousand | 101 Thousand | 67 Thousand |
| Deferred income taxes | - | - | 32 Thousand | 32 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 280 Thousand | -277 Thousand | 2.51 Million | 4.13 Million | 1.13 Million | 1.48 Million |
| Other non-cash items | 797 Thousand | -1.83 Million | 831 Thousand | -1000.00 | 1.34 Million | 184 Thousand |
| Investing Cash Flow | 17 Thousand | -100 Thousand | -42 Thousand | -208 Thousand | -9000.00 | -81 Thousand |
| Investments in PPE | 17 Thousand | -100 Thousand | -42 Thousand | -208 Thousand | -9000.00 | -81 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -45 Thousand | 1.39 Million | -1.38 Million | -1.21 Million | -643 Thousand | -1.34 Million |
| Debt repayment | -45 Thousand | -1.39 Million | -313 Thousand | -2.12 Million | -643 Thousand | -1.34 Million |
| Dividends payments | - | - | - | -389 Thousand | - | - |
| Common Stock Repurchased | - | - | - | -389 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 1.3 Million | - | - |
| Accounts receivables | 879 Thousand | -2.27 Million | 2.52 Million | 4.43 Million | 2.27 Million | 1.53 Million |
| Accounts payables | -599 Thousand | 1.99 Million | -16 Thousand | -305 Thousand | -1.14 Million | -50 Thousand |
| Inventory | - | - | - | - | -2.27 Million | -1.53 Million |
| Other working capital | 879 Thousand | -2.27 Million | -16 Thousand | -305 Thousand | 2.27 Million | 1.53 Million |
| Cash at beginning of period | 30 Thousand | 52 Thousand | 82 Thousand | 23 Thousand | 110 Thousand | 68 Thousand |
| Cash at end of period | - | 30 Thousand | 51 Thousand | 51 Thousand | 82 Thousand | 110 Thousand |
| Capital Expenditure | 17 Thousand | -100 Thousand | -42 Thousand | -208 Thousand | -9000.00 | -81 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -30 Thousand | -22 Thousand | -31 Thousand | 28 Thousand | -28 Thousand | 42 Thousand |
| Free Cash Flow | 15 Thousand | -1.41 Million | 1.35 Million | 1.24 Million | 615 Thousand | 1.38 Million |
NXMR
NBTRF
BPP-R
SNG
WHITEORG
BUR